Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10027478HBVENSG00000103174.13protein_codingNAGPANoNo51172Q9UK23
TVIS10016443HBVENSG00000103174.13protein_codingNAGPANoNo51172Q9UK23
TVIS44036002HTLV-1ENSG00000103174.13protein_codingNAGPANoNo51172Q9UK23
TCGA Plot Options
Drug Information
GeneNAGPA
DrugBank IDDB00141
Drug NameN-Acetylglucosamine
Target IDBE0002266
UniProt IDQ9UK23
Regulation Type
PubMed IDs17139284; 17016423; 8294420; 17927214; 9722550
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Mullis KG, Huynh M, Kornfeld RH: Purification and kinetic parameters of bovine liver N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase. J Biol Chem. 1994 Jan 21;269(3):1718-26.@@Chavez CA, Bohnsack RN, Kudo M, Gotschall RR, Canfield WM, Dahms NM: Domain 5 of the cation-independent mannose 6-phosphate receptor preferentially binds phosphodiesters (mannose 6-phosphate N-acetylglucosamine ester). Biochemistry. 2007 Nov 6;46(44):12604-17. Epub 2007 Oct 10.@@Kornfeld R, Bao M, Brewer K, Noll C, Canfield WM: Purification and multimeric structure of bovine N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase. J Biol Chem. 1998 Sep 4;273(36):23203-10.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationHexoses
SMILES[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO
PathwaysG(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease; Sialuria or French Type Sialuria; Tay-Sachs Disease; Salla Disease/Infantile Sialic Acid Storage Disease; Amino Sugar Metabolism
PharmGKBPA164752287
ChEMBLCHEMBL4303483